Genscript Biotech Stock Investor Sentiment

GNNSF Stock  USD 1.25  0.01  0.79%   
Roughly 61% of Genscript Biotech's investor base is looking to short. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Further weakness as Genscript Biotech drops 16 percent this week, taking three-year losses to 62 per...
Google News at Macroaxis
over six months ago at news.google.com         
Further weakness as Genscript Biotech drops 16 percent this week, taking three-year losses to 62 per...
Google News at Macroaxis
over six months ago at news.google.com         
A Look At The Fair Value Of Genscript Biotech Corporation - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Chinas Genscript hits 3-year low after units downbeat Q1 sales for blood cancer therapy - XM
Google News at Macroaxis
over six months ago at news.google.com         
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment By Investing.com - ...
Google News at Macroaxis
over six months ago at news.google.com         
Genscript Biotech Insiders Sold US11m Of Shares Suggesting Hesitancy - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Investors Appear Satisfied With Genscript Biotech Corporations Prospects As Shares Rocket 29 percent...
Google News at Macroaxis
over six months ago at news.google.com         
Earnings call GenScript Biotech reports robust 2023 results, plans expansion By Investing.com - Inve...
Google News at Macroaxis
over six months ago at news.google.com         
Genscript Biotech Full Year 2023 Earnings EPS Beats Expectations - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Genscript Biotech Trading Up 13.8 percent - American Banking and Market News - AmericanBankingNEWS
Google News at Macroaxis
over six months ago at news.google.com         
Genscript Biotech Corporation Stocks 26 percent Dive Might Signal An Opportunity But It Requires Som...
Google News at Macroaxis
over six months ago at news.google.com         
Genscript Biotech Corporations last weeks 14 percent decline must have disappointed private companie...
Google News at Macroaxis
over a year ago at news.google.com         
GenScript to Host Biotech Global Forum 2024 during 42nd Annual J.P. Morgan Healthcare Conference - M...
Google News at Macroaxis
over a year ago at news.google.com         
Neuroscience Antibodies and Assays Technology Market Rewriting ... - Artrocker
Google News at Macroaxis
over a year ago at news.google.com         
Legend Biotech shares jump nearly 61 percent in U.S. market debut - Reuters
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Genscript Biotech that are available to investors today. That information is available publicly through Genscript media outlets and privately through word of mouth or via Genscript internal channels. However, regardless of the origin, that massive amount of Genscript data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Genscript Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Genscript Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Genscript Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Genscript Biotech alpha.

Genscript Biotech Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Genscript Pink Sheet analysis

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance